The FASEB Journal, Vol 7, 1407-1413, Copyright © 1993 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines

A Puisieux, K Galvin, F Troalen, B Bressac, C Marcais, E Galun, F Ponchel, C Yakicier, J Ji and M Ozturk
Laboratory of Molecular Oncology, Centre Leon Berard, Lyon, France.

We analyzed the status of retinoblastoma and p53 genes in 10 human hepatoma cell lines. Polyclonal anti-peptide antibodies generated against peptides homologous to COOH-terminal and leucine-zipper domains of the retinoblastoma protein allowed us to identify two cell lines (Hep 3B and FOCUS) with abnormal expression. The same cell lines have both lacked p53 expression. In contrast to the retinoblastoma gene, the expression of the p53 gene was abnormal in six additional cell lines. Indeed, only the Hep G2 hepatoblastoma cell line (and its derivative Hep G2/2215) appeared to have normal p53 and retinoblastoma gene expression. Our studies indicate that p53 abnormalities are common but retinoblastoma gene aberrations are rare in human hepatoma cell lines.

This article has been cited by other articles:

				L. Varghese, C. Agarwal, A. Tyagi, R. P. Singh, and R. Agarwal Silibinin Efficacy against Human Hepatocellular Carcinoma Clin. Cancer Res., December 1, 2005; 11(23): 8441 - 8448. [Abstract] [Full Text] [PDF]

				J.-H. Park, L. Liu, I.-H. Kim, J.-H. Kim, K.-R. You, and D.-G. Kim Identification of the Genes Involved in Enhanced Fenretinide-Induced Apoptosis by Parthenolide in Human Hepatoma Cells Cancer Res., April 1, 2005; 65(7): 2804 - 2814. [Abstract] [Full Text] [PDF]

				K. Kooistra, Y.-H. Zhang, N. V. Henriquez, B. Weiss, D. Mumberg, and M. H. M. Noteborn TT virus-derived apoptosis-inducing protein induces apoptosis preferentially in hepatocellular carcinoma-derived cells J. Gen. Virol., June 1, 2004; 85(6): 1445 - 1450. [Abstract] [Full Text] [PDF]

				W. Y. Siu, A. Lau, T. Arooz, J. P.H. Chow, H. T.B. Ho, and R. Y.C. Poon Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms Mol. Cancer Ther., May 1, 2004; 3(5): 621 - 632. [Abstract] [Full Text] [PDF]

				D.-G. Kim, K.-R. You, M.-J. Liu, Y.-K. Choi, and Y.-S. Won GADD153-mediated Anticancer Effects of N-(4-Hydroxyphenyl)retinamide on Human Hepatoma Cells J. Biol. Chem., October 4, 2002; 277(41): 38930 - 38938. [Abstract] [Full Text] [PDF]

				K.-R. You, J. Wen, S.-T. Lee, and D.-G. Kim Cytochrome c Oxidase Subunit III. A MOLECULAR MARKER FOR N-(4-HYDROXYPHENYL)RETINAMIDE-INDUCED OXIDATIVE STRESS IN HEPATOMA CELLS J. Biol. Chem., February 1, 2002; 277(6): 3870 - 3877. [Abstract] [Full Text] [PDF]

				S. A. Nicholson, N. T. Okby, M. A. Khan, J. A. Welsh, M. G. McMenamin, W. D. Travis, J. R. Jett, H. D. Tazelaar, V. Trastek, P. C. Pairolero, et al. Alterations of p14ARF, p53, and p73 Genes Involved in the E2F-1-mediated Apoptotic Pathways in Non-Small Cell Lung Carcinoma Cancer Res., July 1, 2001; 61(14): 5636 - 5643. [Abstract] [Full Text] [PDF]

				T. Soussi p53 Antibodies in the Sera of Patients with Various Types of Cancer: A Review Cancer Res., April 1, 2000; 60(7): 1777 - 1788. [Abstract] [Full Text]

				W. T. Steegenga, A. Shvarts, N. Riteco, J. L. Bos, and A. G. Jochemsen Distinct Regulation of p53 and p73 Activity by Adenovirus E1A, E1B, and E4orf6 Proteins Mol. Cell. Biol., May 1, 1999; 19(5): 3885 - 3894. [Abstract] [Full Text] [PDF]

				G. Fan, X. Ma, B. T. Kren, M. Rice, E. B. Kmiec, and C. J. Steer A Novel Link Between REC2, a DNA Recombinase, the Retinoblastoma Protein, and Apoptosis J. Biol. Chem., August 1, 1997; 272(31): 19413 - 19417. [Abstract] [Full Text] [PDF]

				M. J. Cooper, M. Lippa, J. M. Payne, G. Hatzivassiliou, E. Reifenberg, B. Fayazi, J. C. Perales, L. J. Morrison, D. Templeton, R. L. Piekarz, et al. Safety-modified episomal vectors for human gene therapy PNAS, June 10, 1997; 94(12): 6450 - 6455. [Abstract] [Full Text] [PDF]